{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:06:48Z","timestamp":1788336408063,"version":"build-2803163510"},"reference-count":36,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.2967\/jnmt.121.261998","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T18:00:13Z","timestamp":1638900013000},"page":"248-255","source":"Crossref","is-referenced-by-count":9,"title":["Discordance Between Histopathologic Grading and Dual-Tracer PET\/CT Findings in Metastatic NETs and Outcome of<sup>177<\/sup>Lu-DOTATATE PRRT: Does In\u00a0Vivo Molecular PET Perform Better from the Viewpoint of Prediction of Tumor Biology?"],"prefix":"10.2967","volume":"50","author":[{"given":"Aadil","family":"Adnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"2023061212152955000_50.3.248.1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0108"},{"key":"2023061212152955000_50.3.248.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2004.09.018"},{"key":"2023061212152955000_50.3.248.3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.166"},{"key":"2023061212152955000_50.3.248.4","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2"},{"key":"2023061212152955000_50.3.248.5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","article-title":"The classification of carcinoid tumours","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet."},{"key":"2023061212152955000_50.3.248.6","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-28-15"},{"key":"2023061212152955000_50.3.248.7","first-page":"414","article-title":"A note from history: the saga of carcinoid and oat-cell carcinoma","volume":"38","author":"Hajdu","year":"2008","journal-title":"Ann Clin Lab Sci."},{"key":"2023061212152955000_50.3.248.8","first-page":"181","article-title":"Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of appendicular mucosa","volume":"4","author":"Masson","year":"1928","journal-title":"Am J Pathol."},{"key":"2023061212152955000_50.3.248.9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0022-5223(19)39836-8","article-title":"Atypical carcinoid tumors of the lung","volume":"64","author":"Arrigoni","year":"1972","journal-title":"J Thorac Cardiovasc Surg."},{"key":"2023061212152955000_50.3.248.10","unstructured":"Williams ED. Histological Typing of Endocrine Tumours. Geneva: Springer; 1980."},{"key":"2023061212152955000_50.3.248.11","doi-asserted-by":"publisher","DOI":"10.1148\/rg.276075001"},{"key":"2023061212152955000_50.3.248.12","unstructured":"Vinik A Hughes MS Feliberti E . Carcinoid tumors. National Center for Biotechnology Information website. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279162\/. Updated February 5, 2018. Accessed March 25, 2022."},{"key":"2023061212152955000_50.3.248.13","first-page":"16","article-title":"Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis","volume":"2","author":"Pusceddu","year":"2010","journal-title":"J Thorac Dis."},{"key":"2023061212152955000_50.3.248.14","unstructured":"Axiotis CA . The neuroendocrine lung. In: Li Volsi V Asa SL , eds. Endocrine Pathology. Churchill Livingstone; 2002:261\u2013296."},{"key":"2023061212152955000_50.3.248.15","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0013"},{"key":"2023061212152955000_50.3.248.16","unstructured":"Travis WD . The concept of pulmonary neuroendocrine tumours. In: Travis WD Brambilla E Muller-Hermelink HK Harris CC , eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press; 2004:59\u201364."},{"key":"2023061212152955000_50.3.248.17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/cncy.21457","article-title":"Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010\/ENETS criteria","volume":"122","author":"Farrell","year":"2014","journal-title":"Cancer Cytopathol."},{"key":"2023061212152955000_50.3.248.18","unstructured":"Bosman FT Carneiro F Hruban RH Theise ND . WHO Classification of Tumours of the Digestive System . 4th ed. International Agency for Research on Cancer; 2010."},{"key":"2023061212152955000_50.3.248.19","unstructured":"Neuroendocrine tumors guidelines. Medscape website. http:\/\/emedicine.medscape.com\/article\/2500010-overview. Updated July 27, 2020. Accessed March 25, 2022."},{"key":"2023061212152955000_50.3.248.20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/his.13408","article-title":"Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases","volume":"72","author":"Singhi","year":"2018","journal-title":"Histopathology."},{"key":"2023061212152955000_50.3.248.21","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3181ec124e"},{"key":"2023061212152955000_50.3.248.22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3348\/kjr.2018.0040","article-title":"What is new in the 2017 World Health Organization classification and 8th American Joint Committee on Cancer staging system for pancreatic neuroendocrine neoplasms?","volume":"20","author":"Choe","year":"2019","journal-title":"Korean J Radiol."},{"key":"2023061212152955000_50.3.248.23","unstructured":"Lloyd RV Osamura RY Kl\u00f6ppel G Rosai J . WHO Classification of Tumours of Endocrine Organs . 4th ed. International Agency for Research on Cancer; 2017:209\u2013240."},{"key":"2023061212152955000_50.3.248.24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/MNM.0000000000000321","article-title":"Correlation and discordance of tumour proliferation index and molecular imaging characteristics and their implications for treatment decisions and outcome pertaining to peptide receptor radionuclide therapy in patients with advanced neuroendocrine tumour","volume":"36","author":"Basu","year":"2015","journal-title":"Nucl Med Commun."},{"key":"2023061212152955000_50.3.248.25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0548"},{"key":"2023061212152955000_50.3.248.26","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0364"},{"key":"2023061212152955000_50.3.248.27","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2012.0026"},{"key":"2023061212152955000_50.3.248.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0748-7983(97)80140-0"},{"key":"2023061212152955000_50.3.248.29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00428-011-1060-7","article-title":"The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers","volume":"458","author":"Volante","year":"2011","journal-title":"Virchows Arch."},{"key":"2023061212152955000_50.3.248.30","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1097\/MNM.0000000000000547","article-title":"Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics","volume":"37","author":"Thapa","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2023061212152955000_50.3.248.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.241414"},{"key":"2023061212152955000_50.3.248.32","first-page":"178","article-title":"One decade of \u2018bench-to-bedside\u2019 peptide receptor radionuclide therapy with indigenous [177Lu]Lu-DOTATATE obtained through \u2018direct\u2019 neutron activation route: lessons learnt including practice evolution in an Indian setting","volume":"10","author":"Basu","year":"2020","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"2023061212152955000_50.3.248.33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.semnuclmed.2020.05.004","article-title":"Kamaldeep CS. Peptide receptor radionuclide therapy of neuroendocrine tumors","volume":"50","author":"Basu","year":"2020","journal-title":"Semin Nucl Med."},{"key":"2023061212152955000_50.3.248.34","doi-asserted-by":"crossref","first-page":"20201041","DOI":"10.1259\/bjr.20201041","article-title":"Long-term outcome of indigenous 177Lu-DOTATATE PRRT in patients with metastatic advanced neuroendocrine tumours: a single institutional observation in a large tertiary care setting","volume":"94","author":"Sitani","year":"2021","journal-title":"Br J Radiol."},{"key":"2023061212152955000_50.3.248.35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/wjnm.WJNM_62_18","article-title":"Implications of fluorodeoxyglucose uptake in low-intermediate grade metastatic neuroendocrine tumors from peptide receptor radionuclide therapy outcome viewpoint: a semi-quantitative standardized uptake value-based analysis","volume":"18","author":"Adnan","year":"2019","journal-title":"World J Nucl Med."},{"key":"2023061212152955000_50.3.248.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.116.185777"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.121.261998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T19:16:14Z","timestamp":1686597374000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.121.261998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.2967\/jnmt.121.261998"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.121.261998","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}